spike protein Archives

The Trend Reduction In COVID-19 Daily Deaths.

30 April 2022

SARS-CoV-2 Was Waving A White Flag By June 2020. Since the onset of the Great Insanity we have been following the COVID-19 mortality rate and total deaths on a daily basis, as mortality rate is ultimately the best measure of infectivity, i.e. the damage to human health that a pathogen can cause. For an explanation […]

What Makes SARS-CoV-2 More Infectious.

12 February 2022

The Role Of The RBM:ACE2 Interface. A little over a year ago, we set out how increased infectiousness meant greater vulnerability, i.e. a new variant may be more infectious but it is also more susceptible to destruction by the innate immune response. The chances are that most people now know what a structural spike protein […]

Nitric Oxide’s Role In Anti-Adhesion And Anti-Coagulation.

13 December 2021

Background. SARS-CoV-2’s Achilles’ heel has always been vitamin D in general and nitric oxide in particular. We first explained the relevance of vitamin D in July 2020, identifying the correlation between vitamin D deficiency and COVID-19 mortality rates and the key role of exposure to photosynthesis of vitamin D from exposure to UVB that occurs […]

Yet Another Virus That Provides SARS-CoV-2 Immunity.

15 November 2021

Background. It is difficult to select the most fundamental error relating to SARS-CoV-2: the deliberate confusion of ‘infectiousness’ with ‘infectivity’; the deliberate use of ‘COVID-19’ disease severity when one is referring to ‘SARS-CoV-2’ viral infection, for example ‘rising COVID-19 infections’ when there is no such thing; the use of ‘vaccination’ when the correct description is […]

Cathelicidin – Another Key Benefit Of Vitamin D.

29 October 2021

Background. It is impossible to ignore the pivotal role of vitamin D both in preventing SARS-CoV-2 viral infection (through the eNOS→nitric oxide pathway) and in reducing COVID-19 disease severity (through the cholecalciferol→ calcifediol→calcitriol pathway). As early as July 2020 we had identified the positive correlation between COVID-19 mortality rate and vitamin D deficiency. By October […]

Antiphospholipid Antibodies And COVID-19 Vaccines.

25 August 2021

Background. As early as October 2020 – over ten months ago – we explained why a vaccine was not needed and would not be effective. That’s a vaccine using its correct medical definition, i.e. a prophylactic treatment providing long-term or lifetime protection. All of the four main treatment candidates being injected – Vaxzevria; BNT126b2; mRNA-1273 […]

Why Delta / B1.617.2 Is NOT A Problem.

6 July 2021

Just What Is Different About Delta? B1.617.2/Delta is apparently still spreading. This is unsurprising given that it has been occurring globally for over eight months. At least the WHO has finally applied a nomenclature to the main SARS-CoV-2 variants, adding to the existing PANGO and Nextstrain designations. This validates something we first highlighted four months […]

SARS-COV-2’s Defences Against Detection.

18 May 2021

What Variants Want. Considerable coverage is being given to variant B1.617. This is the ‘Indian’ variant if you use the incorrect basis of giving single country, geographical names to variants that appear globally across multiple variants and are not new, having been in existence for months and in some cases, over a year. As part […]

Questions For Those Offering You A ‘Vaccine’.

4 May 2021

Beware ‘Excited’ Non-Healthcare Workers. As another cohort is now to be offered the antivirals (they are not vaccines), it is apposite to set out some questions to ask those who are falling over themselves to vaccinate you. There is an irony in the fact that reception staff at GPs’ surgeries who are usually obdurate and […]

Is Ivermectin Another ‘Wonderdrug’?

21 April 2021

Is This Remdesivirmania Redux? Ivermectin is the subject of increasing coverage and concomitant hysteria around it being another ‘wonderdrug’ for the treatment of SARS-CoV-2. It has been touted as a potential treatment since the days of remdesivir, chloroquine, hydroxychloroquine and lopinavir. We picked apart remdesivir in October 2020, days after it was approved by the […]